-
EP1620562
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP1620562
| Cited in | Search | Type: | Patent literature | Publication No.: | WO9949042
[X] (ICOS CORP [US]) [X] 4,5 * page 36, lines 10-18 *; | Type: | Patent literature | Publication No.: | WO03012125
[X] (RIGEL PHARMACEUTICALS INC [US], et al) [X] 1-11,13,15,47-51,53-55 * abstract * * page 29, line 6 - page 33, line 12; figure 29 *; | Type: | Non-patent literature | Publication information: | [X] - ELLER MARK S ET AL, "Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.", FASEB JOURNAL, (200302), vol. 17, no. 2, ISSN 0892-6638, pages 152 - 162, XP002417039 [X] 53-56 * abstract * * page 152, column 1, paragraph 2 - page 153, column 2, paragraph 2 * * page 159, column 2, paragraph 2 - page 160, column 2, paragraph 2 * * figure 9 * | DOI: | http://dx.doi.org/10.1096/fj.02-0197com | Type: | Non-patent literature | Publication information: | [X] - PAULL TANYA T ET AL, "A mechanistic basis for Mre11-directed DNA joining at microhomologies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (20000606), vol. 97, no. 12, ISSN 0027-8424, pages 6409 - 6414, XP002417040 [X] 1-4,8,9,53-55 * abstract * * page 6409, column 1, paragraph 2 - column 2, paragraph 3 * * page 6411, column 1, paragraph 4 - page 6412, column 2, paragraph 1 * * page 6413, column 2, paragraphs 2-4 * | DOI: | http://dx.doi.org/10.1073/pnas.110144297 | Type: | Non-patent literature | Publication information: | [A] - LI GUANG-ZHI ET AL, "Evidence that exposure of the telomere 3' overhang sequence induces senescence.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (20030121), vol. 100, no. 2, ISSN 0027-8424, pages 527 - 531, XP002972897 [A] * abstract * * page 528, column 2, paragraph 1 * * page 529, column 1, paragraph 2 - page 531, column 2, paragraph 2; figure 5 * | DOI: | http://dx.doi.org/10.1073/pnas.0235444100 | Type: | Non-patent literature | Publication information: | [A] - PETRINI J H J ET AL, "ISOLATION AND CHARACTERIZATION OF THE HUMAN MRE11 HOMOLOGUE", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (199509), vol. 29, no. 1, ISSN 0888-7543, pages 80 - 86, XP002941671 [A] * abstract * | DOI: | http://dx.doi.org/10.1006/geno.1995.1217 | Type: | Non-patent literature | Publication information: | [PX] - XU M ET AL, "Treatment of cells with Mre11 siRNA increases radiation sensitivity and reduces heat induced radiosensitization.", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, & 45TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY; SALT LAKE CITY, UTAH, USA; OCTOBER 19-23, 2003, (2003), vol. 57, no. 2 Supplement, ISSN 0360-3016, pages S144 - S145, XP002417041 [PX] 4,5 * abstract * | DOI: | http://dx.doi.org/10.1016/S0360-3016(03)00909-X | Cited in | International search | Type: | Patent literature | Publication No.: | US5958680
[X] (VILLEPONTEAU BRYANT [US], et al); | Type: | Non-patent literature | Publication information: | [X] - ANSELMET ET AL., "Non-antisense cellular responses to oligonucleotides", FEBS LETTERS, (20020116), vol. 510, no. 3, pages 175 - 180, XP004332636 | DOI: | http://dx.doi.org/10.1016/S0014-5793(01)03248-3 | Type: | Non-patent literature | Publication information: | [X] - GLUKHOV ET AL., "Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (19980720), vol. 248, no. 2, pages 368 - 371, XP000961269 | DOI: | http://dx.doi.org/10.1006/bbrc.1998.8801 | Type: | Non-patent literature | Publication information: | [X] - ZHIHUI ET AL., "Inhibitory effect of a liposome-mediated antisense oligodeoxynucleotide on telomerase activity in a human gastric cancer cell line", CHINESE JOURNAL OF DIGESTIVE DISEASES, (2001), vol. 2, pages 65 - 68, XP003012222 | DOI: | http://dx.doi.org/10.1046/j.1443-9573.2001.00031.x |